Amiko is a digital health company that designs and develops advanced sensor technologies, connectivity and artificial intelligence for healthcare systems and drug delivery devices. The company’s first product is Respiro, which is comprised of add-on sensors for existing inhalers.
Amiko develops advanced sensor technologies and digital health solutions to assist healthcare professionals and empower patients to achieve better outcomes. Founded in 2015, Amiko has headquarters in London, UK, and ISO 13485:2016 certified R&D laboratories in Milan, Italy. Amiko serves commercial, institutional and individual customers all over the world, and is growing to become a global provider of advanced medication sensor and data analytics technologies.